Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Rezaei

Showing results (11-20 of 1,192) with videos related to

Pageof 120
Sort By:
Immunity, Inflammation and Disease|April 28, 2022
SARS-CoV-2 Omicron variant: Why global communities should take it seriously?Shayan Rahmani, Nima Rezaei
Journal of Translational Medicine|August 16, 2023
Eosinophils in the tumor microenvironment: implications for cancer immunotherapySasan Ghaffari, Nima Rezaei
Expert Review of Clinical Immunology|September 26, 2023
Immune-scoring in head and neck squamous cell carcinoma: a scoping reviewRaha Zamani, Nima Rezaei
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2020
CRISPR/Cas13: A potential therapeutic option of COVID-19Melika Lotfi, Nima Rezaei
The American Journal of Emergency Medicine|September 29, 2020
COVID-19 pandemic is not the time of trial and errorKawthar Mohamed, Nima Rezaei
Health Science Reports|August 29, 2022
Anaphylaxis and allergic reactions to COVID-19 vaccines: A narrative review of characteristics and potential obstacles on achieving herd immunitySara Mahdiabadi, Nima Rezaei
Archives of Medical Research|May 15, 2020
COVID-19: Developing from an Outbreak to A PandemicSara Hanaei, Nima Rezaei
Expert Opinion on Biological Therapy|December 1, 2022
CAR-NK cells: a promising cellular immunotherapy in lymphomaShaghayegh Khanmohammadi, Nima Rezaei
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!Shayan Rahmani, Nima Rezaei
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
Evaluating COVID-19-Environment FitAmene Saghazadeh, Nima Rezaei
Pageof 120

Showing results (11-20 of 1,192) with videos related to

Sort By:
Pageof 120
Immunity, Inflammation and Disease|April 28, 2022
SARS-CoV-2 Omicron variant: Why global communities should take it seriously?Shayan Rahmani, Nima Rezaei
Journal of Translational Medicine|August 16, 2023
Eosinophils in the tumor microenvironment: implications for cancer immunotherapySasan Ghaffari, Nima Rezaei
Expert Review of Clinical Immunology|September 26, 2023
Immune-scoring in head and neck squamous cell carcinoma: a scoping reviewRaha Zamani, Nima Rezaei
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2020
CRISPR/Cas13: A potential therapeutic option of COVID-19Melika Lotfi, Nima Rezaei
The American Journal of Emergency Medicine|September 29, 2020
COVID-19 pandemic is not the time of trial and errorKawthar Mohamed, Nima Rezaei
Health Science Reports|August 29, 2022
Anaphylaxis and allergic reactions to COVID-19 vaccines: A narrative review of characteristics and potential obstacles on achieving herd immunitySara Mahdiabadi, Nima Rezaei
Archives of Medical Research|May 15, 2020
COVID-19: Developing from an Outbreak to A PandemicSara Hanaei, Nima Rezaei
Expert Opinion on Biological Therapy|December 1, 2022
CAR-NK cells: a promising cellular immunotherapy in lymphomaShaghayegh Khanmohammadi, Nima Rezaei
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!Shayan Rahmani, Nima Rezaei
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
Evaluating COVID-19-Environment FitAmene Saghazadeh, Nima Rezaei
Pageof 120